当前位置: 首页 >> 检索结果
共有 1294 条符合本次的查询结果, 用时 2.4830518 秒

481. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma.

作者: T Sabharwal.;M S Hamady.;S Chui.;S Atkinson.;R Mason.;A Adam.
来源: Gut. 2003年52卷7期922-6页
Covered metallic oesophageal stents offer effective palliation of malignant oesophageal strictures. However, first generation devices were associated with a high rate of migration, particularly when used in the lower oesophagus.

482. Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study.

作者: C J Hawkey.;L Laine.;T Simon.;H Quan.;S Shingo.;J Evans.; .
来源: Gut. 2003年52卷6期820-6页
Previous studies in patients with osteoarthritis have suggested that the selective cyclooxygenase (COX)-2 inhibitor rofecoxib results in less gastrointestinal damage than non-selective non-steroidal antiinflammatory drugs (NSAIDs). This study compared the incidence of endoscopically detected gastroduodenal ulcers in rheumatoid arthritis patients treated with rofecoxib or a non-selective NSAID.

483. Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon non-responsive chronic hepatitis C: a randomised trial.

作者: L E Adinolfi.;R Utili.;A Tonziello.;G Ruggiero.
来源: Gut. 2003年52卷5期701-5页
Fifty per cent of chronic hepatitis C patients are non-responders to interferon. At present, there are no recommended therapeutic options for non-responders.

484. An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome.

作者: J Kellow.;O Y Lee.;F Y Chang.;S Thongsawat.;M Z Mazlam.;H Yuen.;K A Gwee.;Y T Bak.;J Jones.;A Wagner.
来源: Gut. 2003年52卷5期671-6页
Tegaserod has been shown to be an effective therapy for the multiple symptoms of irritable bowel syndrome (IBS) in Western populations. However, little information is available regarding the use of tegaserod in the Asia-Pacific population.

485. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease.

作者: A F Ciccaglione.;L Marzio.
来源: Gut. 2003年52卷4期464-70页
The gamma-aminobutyric acid (GABA(B)) agonist baclofen has been shown to reduce reflux episodes during the first three postprandial hours in patients with gastro-oesophageal reflux disease (GORD) and in normal controls. The aim of the study was to assess the effect of acute (one day) and chronic (four weeks) administration of baclofen on 24 hour pH metry and symptoms in GORD patients and normal controls.

486. Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.

作者: U Siebert.;G Sroczynski.;S Rossol.;J Wasem.;U Ravens-Sieberer.;B M Kurth.;M P Manns.;J G McHutchison.;J B Wong.; .; .
来源: Gut. 2003年52卷3期425-32页
Peginterferon alpha-2b plus ribavirin therapy in previously untreated patients with chronic hepatitis C yields the highest sustained virological response rates of any treatment strategy but is expensive.

487. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.

作者: T Bizollon.;S N S Ahmed.;S Radenne.;M Chevallier.;P Chevallier.;P Parvaz.;S Guichard.;C Ducerf.;J Baulieux.;F Zoulim.;C Trepo.
来源: Gut. 2003年52卷2期283-7页
A proportion of liver transplanted patients with recurrent chronic hepatitis have a sustained virological response to combination therapy with interferon plus ribavirin. However, the long term benefit of antiviral therapy with regard to hepatitis C virus (HCV) RNA clearance remains unknown in patients with HCV recurrence. This study examined the long term biochemical, virological, and histological outcome in transplanted patients with recurrent chronic hepatitis who had a sustained virological response to antiviral therapy.

488. A dose finding study with 0.1%, 0.2%, and 0.4% glyceryl trinitrate ointment in patients with chronic anal fissures.

作者: J H Scholefield.;J U Bock.;B Marla.;H J Richter.;S Athanasiadis.;M Pröls.;A Herold.
来源: Gut. 2003年52卷2期264-9页
Anal fissure is a common painful condition affecting the anal canal. The majority of acute fissures heal spontaneously. However, some of these acute fissures do not resolve but become chronic. Chronic anal fissures were traditionally treated by anal dilation or by lateral sphincterotomy. However, both of these surgical treatments may cause a degree of incontinence in up to 30% of patients. Several recent trials have shown that nitric oxide donors such as glyceryl trinitrate (GTN) can reduce sphincter pressure and heal up to 70% of chronic fissures.

489. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis.

作者: O K Bonderup.;J B Hansen.;L Birket-Smith.;V Vestergaard.;P S Teglbjaerg.;J Fallingborg.
来源: Gut. 2003年52卷2期248-51页
Collagenous colitis is characterised by diarrhoea, lymphocytic inflammation, and a thickened subepithelial collagen layer in the colorectal mucosa. No standard treatment of the disease is established.

490. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.

作者: I J A M Jonkers.;A H M Smelt.;M Ledeboer.;M E Hollum.;I Biemond.;F Kuipers.;F Stellaard.;R Boverhof.;A E Meinders.;C H B W Lamers.;A A M Masclee.
来源: Gut. 2003年52卷1期109-15页
The aim of this study was to unravel the mechanisms responsible for the increased risk of gall stone disease in hypertriglyceridaemia (HTG) and to compare the effects of triglyceride lowering therapy by bezafibrate and fish oil on determinants of cholelithiasis (biliary lipid composition and gall bladder motility) in HTG patients.

491. Tachykinins potently stimulate human small bowel blood flow: a laser Doppler flowmetry study in humans.

作者: P T Schmidt.;M Lördal.;B Gazelius.;P M Hellström.
来源: Gut. 2003年52卷1期53-6页
The two tachykinins substance P and neurokinin A are abundantly present in the gastrointestinal tract. Substance P preferring neurokinin 1 receptors are mainly found in submucosal blood vessels while neurokinin A preferring neurokinin 2 receptors seem to be confined to smooth muscle cells. Tachykinin effects on intestinal mucosal blood flow in humans are not known.

492. Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.

作者: H R Koelz.;R Arnold.;M Stolte.;M Fischer.;A L Blum.; .
来源: Gut. 2003年52卷1期40-6页
Previous studies on the treatment of Helicobacter pylori infection in functional dyspepsia have shown little, if any, effect on dyspeptic symptoms. However, whether such treatment might be of benefit in patients resistant to acid inhibitors has not been formally tested.

493. Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinal sterol absorption also regulate biliary secretion.

作者: T Sudhop.;Y Sahin.;B Lindenthal.;C Hahn.;C Lüers.;H K Berthold.;K von Bergmann.
来源: Gut. 2002年51卷6期860-3页
Recently identified ABCG5/8 transporters are responsible in part for the different absorption rates of campesterol, sitosterol, and cholesterol. These transporters are also expressed in the liver and might regulate biliary sterol secretion.

494. A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients.

作者: C E McNaught.;N P Woodcock.;J MacFie.;C J Mitchell.
来源: Gut. 2002年51卷6期827-31页
Bacterial translocation occurs in surgical patients and may predispose to postoperative septic morbidity. Many factors are thought to influence the prevalence of bacterial translocation, one of which is the composition of the gut microflora. The aim of this prospective and randomised study was to assess the effect of the probiotic Lactobacillus plantarum 299v on the incidence of bacterial translocation, gastric colonisation, and septic complications in elective surgical patients.

495. Visceral sensation and emotion: a study using hypnosis.

作者: L A Houghton.;E L Calvert.;N A Jackson.;P Cooper.;P J Whorwell.
来源: Gut. 2002年51卷5期701-4页
We have previously shown that hypnosis can be used to study the effect of different emotions on the motility of the gastrointestinal tract. These studies demonstrated that both anger and excitement increased colonic motility while happiness led to a reduction. The purpose of this study was to investigate the effect of hypnotically induced emotion on the visceral sensitivity of the gut.

496. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers.

作者: S Banerjee.;A Medina-Fatimi.;R Nichols.;D Tendler.;M Michetti.;J Simon.;C P Kelly.;T P Monath.;P Michetti.
来源: Gut. 2002年51卷5期634-40页
Escherichia coli heat labile enterotoxin (LT) at doses of 5 micro g or 10 micro g has adjuvant activity for oral immunisation in humans infected with Helicobacter pylori, but causes severe diarrhoea. This study was undertaken to establish a safe and effective dose of LT, to confirm the safety of recombinant urease, and to compare the immunogenicity of orally compared with enterically delivered urease.

497. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients.

作者: W M Wong.;B C Y Wong.;W K Hung.;Y K Yee.;A W C Yip.;M L Szeto.;F M Y Fung.;T S M Tong.;K C Lai.;W H C Hu.;M F Yuen.;S K Lam.
来源: Gut. 2002年51卷4期502-6页
The use of proton pump inhibitors for the treatment of functional dyspepsia is controversial and the role of Helicobacter pylori infection in functional dyspepsia is uncertain.

498. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

作者: C Prantera.;M L Scribano.;G Falasco.;A Andreoli.;C Luzi.
来源: Gut. 2002年51卷3期405-9页
Experimental studies have shown that luminal bacteria may be involved in Crohn's disease. Probiotics are a possible alternative to antibiotics. The aim of this randomised placebo controlled study was to determine if Lactobacillus GG, given by mouth for one year, could prevent Crohn's recurrent lesions after surgery or to reduce their severity.

499. Mucin gene expression in the ileoanal reservoir is altered and may be relevant to the risk of inflammation and dysplasia.

作者: P A Sylvester.;M Walsh.;N Myerscough.;B F Warren.;A P Corfield.;M G Thomas.;P Durdey.
来源: Gut. 2002年51卷3期386-91页
Adaptive colonic phenotypic change of the ileal mucosa is a feature of the ileoanal reservoir (IAR) with time, as described by mucin glycoprotein and histological analysis. Mucin gene expression is altered in colorectal neoplasia and inflammatory bowel disease but little is known of its expression in the IAR.

500. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.

作者: J Labenz.;A L Blum.;W W Bolten.;B Dragosics.;W Rösch.;M Stolte.;H R Koelz.
来源: Gut. 2002年51卷3期329-35页
There is much controversy as to whether or not treatment of Helicobacter pylori reduces the occurrence of peptic ulcers during therapy with a non-steroidal anti-inflammatory drug (NSAID).
共有 1294 条符合本次的查询结果, 用时 2.4830518 秒